In a study examining immunogenic effects of CDDP, Beyranvand and colleagues demonstrated that CDDP can enhance tumor cell death with the assistance of CTLs activated by CD80/86-mediated costimulation [99]. The gene discussed is CD80; the disease is neoplasm.